231 related articles for article (PubMed ID: 24756923)
1. Copper-free click-chemistry platform to functionalize cisplatin prodrugs.
Pathak RK; McNitt CD; Popik VV; Dhar S
Chemistry; 2014 Jun; 20(23):6861-5. PubMed ID: 24756923
[TBL] [Abstract][Full Text] [Related]
2. Emerging platinum(iv) prodrugs to combat cisplatin resistance: from isolated cancer cells to tumor microenvironment.
Wang Z; Deng Z; Zhu G
Dalton Trans; 2019 Feb; 48(8):2536-2544. PubMed ID: 30633263
[TBL] [Abstract][Full Text] [Related]
3. Exploiting azide-alkyne click chemistry in the synthesis, tracking and targeting of platinum anticancer complexes.
Farrer NJ; Griffith DM
Curr Opin Chem Biol; 2020 Apr; 55():59-68. PubMed ID: 31945705
[TBL] [Abstract][Full Text] [Related]
4. Multiaction Pt(IV) Carbamate Complexes Can Codeliver Pt(II) Drugs and Amine Containing Bioactive Molecules.
Babu T; Sarkar A; Karmakar S; Schmidt C; Gibson D
Inorg Chem; 2020 Apr; 59(7):5182-5193. PubMed ID: 32207294
[TBL] [Abstract][Full Text] [Related]
5. Well-defined diimine copper(I) complexes as catalysts in click azide-alkyne cycloaddition reactions.
Barta JM; Díez-González S
Molecules; 2013 Jul; 18(8):8919-28. PubMed ID: 23896617
[TBL] [Abstract][Full Text] [Related]
6. Layer-by-layer assembled polypeptide capsules for platinum-based pro-drug delivery.
Zhou D; Xiao H; Meng F; Zhou S; Guo J; Li X; Jing X; Huang Y
Bioconjug Chem; 2012 Dec; 23(12):2335-43. PubMed ID: 23176570
[TBL] [Abstract][Full Text] [Related]
7.
Lee VEY; Lim ZC; Chew SL; Ang WH
Inorg Chem; 2021 Feb; 60(3):1823-1831. PubMed ID: 33464875
[TBL] [Abstract][Full Text] [Related]
8. Copper-free azide-alkyne cycloaddition of targeting peptides to porous silicon nanoparticles for intracellular drug uptake.
Wang CF; Mäkilä EM; Kaasalainen MH; Liu D; Sarparanta MP; Airaksinen AJ; Salonen JJ; Hirvonen JT; Santos HA
Biomaterials; 2014 Jan; 35(4):1257-66. PubMed ID: 24211082
[TBL] [Abstract][Full Text] [Related]
9. Immuno-chemotherapeutic platinum(IV) prodrugs of cisplatin as multimodal anticancer agents.
Wong DY; Yeo CH; Ang WH
Angew Chem Int Ed Engl; 2014 Jun; 53(26):6752-6. PubMed ID: 24844571
[TBL] [Abstract][Full Text] [Related]
10. Pt(IV) complexes as prodrugs for cisplatin.
Shi Y; Liu SA; Kerwood DJ; Goodisman J; Dabrowiak JC
J Inorg Biochem; 2012 Feb; 107(1):6-14. PubMed ID: 22169035
[TBL] [Abstract][Full Text] [Related]
11. The role of the equatorial ligands for the redox behavior, mode of cellular accumulation and cytotoxicity of platinum(IV) prodrugs.
Göschl S; Varbanov HP; Theiner S; Jakupec MA; Galanski MS; Keppler BK
J Inorg Biochem; 2016 Jul; 160():264-74. PubMed ID: 27055943
[TBL] [Abstract][Full Text] [Related]
12. Antiproliferative activity of a series of cisplatin-based Pt(IV)-acetylamido/carboxylato prodrugs.
Ravera M; Gabano E; Zanellato I; Fregonese F; Pelosi G; Platts JA; Osella D
Dalton Trans; 2016 Mar; 45(12):5300-9. PubMed ID: 26903367
[TBL] [Abstract][Full Text] [Related]
13. Platinum(iv) prodrugs with long lipid chains for drug delivery and overcoming cisplatin resistance.
Chen Q; Yang Y; Lin X; Ma W; Chen G; Li W; Wang X; Yu Z
Chem Commun (Camb); 2018 May; 54(42):5369-5372. PubMed ID: 29744485
[TBL] [Abstract][Full Text] [Related]
14. An unsymmetric cisplatin-based Pt(iv) derivative containing 2-(2-propynyl)octanoate: a very efficient multi-action antitumor prodrug candidate.
Gabano E; Ravera M; Zanellato I; Tinello S; Gallina A; Rangone B; Gandin V; Marzano C; Bottone MG; Osella D
Dalton Trans; 2017 Oct; 46(41):14174-14185. PubMed ID: 28984330
[TBL] [Abstract][Full Text] [Related]
15. An Anticancer Pt
Kostrhunova H; Petruzzella E; Gibson D; Kasparkova J; Brabec V
Chemistry; 2019 Apr; 25(20):5235-5245. PubMed ID: 30740808
[TBL] [Abstract][Full Text] [Related]
16. An alkyne-appended, click-ready Pt(II) complex with an unusual arrangement in the solid state.
White JD; Guzman LE; Zakharov LN; Haley MM; DeRose VJ
Angew Chem Int Ed Engl; 2015 Jan; 54(3):1032-5. PubMed ID: 25429919
[TBL] [Abstract][Full Text] [Related]
17. Functionalized nonporous silica nanoparticles as carriers for Pt(iv) anticancer prodrugs.
Ravera M; Gabano E; Zanellato I; Perin E; Arrais A; Osella D
Dalton Trans; 2016 Nov; 45(43):17233-17240. PubMed ID: 27722707
[TBL] [Abstract][Full Text] [Related]
18. A Cancer Cell-Selective and Low-Toxic Bifunctional Heterodinuclear Pt(IV)-Ru(II) Anticancer Prodrug.
Ma L; Lin X; Li C; Xu Z; Chan CY; Tse MK; Shi P; Zhu G
Inorg Chem; 2018 Mar; 57(5):2917-2924. PubMed ID: 29436828
[TBL] [Abstract][Full Text] [Related]
19. Heterodinuclear Pt(iv)-Ru(ii) anticancer prodrugs to combat both drug resistance and tumor metastasis.
Ma L; Ma R; Wang Z; Yiu SM; Zhu G
Chem Commun (Camb); 2016 Sep; 52(71):10735-8. PubMed ID: 27506281
[TBL] [Abstract][Full Text] [Related]
20. Development of Novel Pt(IV)-Carbohydrate Derivatives as Targeted Anticancer Agents against Osteosarcoma.
Moynihan E; Panseri S; Bassi G; Rossi A; Campodoni E; Dempsey E; Montesi M; Velasco-Torrijos T; Montagner D
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
